NRG Oncology, Protocol: NRG-GY020, PI: Dr. Mcnamara, Title: A Phase III Randomized Trial Of Radiation +/- Mk-3475 (Pembrolizumab) For Actively Diagnosed Early Stage High Intermediate Risk Mismatch Repair Deficient (Dmmr) Endometrioid Endometrial Cancer